Adds STAAR Surgical comment. STAAR Surgical (STAA) dropped 5% after proxy adviser Glass Lewis recommended holders reject the ...

STAAR Surgical's major shareholder intends to vote against the acquisition, stating the price still significantly undervalues ...

Alcon announced that it entered into an amended merger agreement for its planned acquisition of Staar Surgical.

Swiss eyecare giant Alcon has made a new offer for Staar Surgical worth $1.6 billion, it said on Tuesday, as it seeks to ...

Bank of America has taken a sharper turn on Alcon , issuing a double downgrade that shifts the Swiss eye-care group from buy ...

The amended offer adds $150 million to Alcon’s original offer of $28 per share, or $1.5 billion, announced back in August.

The activist investor Broadwood, which owns 30.2% of Staar's stock, said it believes Staar is worth substantially more than the new, higher offer from Alcon. It said it would vote against the revised ...

STAAR Surgical ( STAA) soared 10% after Alcon ( ALC) increased its offer for STAAR to $30.75/share in cash. The purchase ...

Alcon increases its acquisition offer for STAAR Surgical, emphasizing a final deal amid shareholder debates and delays in the ...

Major STAAR shareholders reject Alcon's increased $30.75 bid, citing a flawed sale process, insufficient valuation, and ...

Investing.com -- Bank of America double downgraded Alcon to Underperform and cut its price objective to 60 CHF from 80 CHF, ...

Eye care company Alcon will offer $150 million more to buy Staar Surgical. Under the terms of the amended agreement, Alcon will purchase all outstanding shares of Staar, for $30.75 per share in cash.